{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:50:29Z","timestamp":1783770629710,"version":"3.55.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.msard.2025.106579","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T02:54:36Z","timestamp":1749524076000},"page":"106579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Navigating challenges and embracing opportunities toward achieving equitable multiple sclerosis care"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5053-8544","authenticated-orcid":false,"given":"Albert","family":"Aboseif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin R.","family":"Abbatemarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa P.","family":"McGinley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"O\u2019Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon S.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhun H.","family":"Kantarci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ontaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilyana","family":"Amezcua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5716-5645","authenticated-orcid":false,"given":"Carrie M.","family":"Hersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106579_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103734","article-title":"Association of socioeconomic disadvantage and neighborhood disparities with clinical outcomes in MS patients","volume":"61","author":"Abbatemarco","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2025.106579_bib0002","first-page":"13","article-title":"Evaluating heterogeneous treatment effects in pursuit of personalized multiple sclerosis care","volume":"24","author":"Aboseif","year":"2025","journal-title":"Pract. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106579_bib0003","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ncl.2023.06.003","article-title":"Leveraging real-world evidence and observational studies in treating MS","volume":"42","author":"Aboseif","year":"2024","journal-title":"Neurol. Clin."},{"issue":"1","key":"10.1016\/j.msard.2025.106579_bib0004","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1352458516638746","article-title":"Ethnicity and prevalence of multiple sclerosis in east London","volume":"23","author":"Albor","year":"2017","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2025.106579_bib0005","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213332","article-title":"Person-centered social determinants and neighborhood-level deprivation associated with disability in hispanic people with multiple sclerosis","volume":"104","author":"Amezcua","year":"2025","journal-title":"Neurology"},{"issue":"11\u201312","key":"10.1016\/j.msard.2025.106579_bib0006","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1177\/13524585241286988","article-title":"The current state of diversity, equity, and inclusion in multiple sclerosis research, clinical trials, and workforce","volume":"30","author":"Amezcua","year":"2024","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.msard.2025.106579_bib0007","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1177\/1352458511403025","article-title":"Multiple sclerosis in Hispanics: a study of clinical disease expression","volume":"17","author":"Amezcua","year":"2011","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.msard.2025.106579_bib0008","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jamaneurol.2021.3416","article-title":"Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: a review","volume":"78","author":"Amezcua","year":"2021","journal-title":"JAMa Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106579_bib0009","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/nmt-2021-0058","article-title":"Updates and advances in multiple sclerosis neurotherapeutics","volume":"13","author":"Amin","year":"2023","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.msard.2025.106579_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2022.103101","article-title":"Sensitivity of portable low-field magnetic resonance imaging for multiple sclerosis lesions","volume":"35","author":"Arnold","year":"2022","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.msard.2025.106579_bib0011","first-page":"1","article-title":"Geographical variation in medication and health resource use in multiple sclerosis","volume":"11","author":"Balcom","year":"2024","journal-title":"Can. J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2025.106579_bib0012","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210251","article-title":"Inequities in the use of disease-modifying therapy among adults living with multiple sclerosis in urban and rural areas in Alberta, Canada","volume":"104","author":"Balcom","year":"2025","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/j.msard.2025.106579_bib0013","doi-asserted-by":"crossref","first-page":"e1778","DOI":"10.1212\/WNL.0000000000008189","article-title":"Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis","volume":"93","author":"Barkhof","year":"2019","journal-title":"Neurology"},{"issue":"18","key":"10.1016\/j.msard.2025.106579_bib0014","doi-asserted-by":"crossref","first-page":"e1810","DOI":"10.1212\/WNL.0000000000200150","article-title":"The economic burden of multiple sclerosis in the United States: estimate of direct and indirect costs","volume":"98","author":"Bebo","year":"2022","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2025.106579_bib0015","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/1352458514554055","article-title":"Prevalence of multiple sclerosis among immigrants in Norway","volume":"21","author":"Berg-Hansen","year":"2015","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2025.106579_bib0016","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1352458515579444","article-title":"Level of education and multiple sclerosis risk after adjustment for known risk factors: the EnvIMS study","volume":"22","author":"Bj\u00f8rnevik","year":"2016","journal-title":"Mult. Scler."},{"issue":"7 Suppl 1","key":"10.1016\/j.msard.2025.106579_bib0017","first-page":"S27","article-title":"Use of community-engaged research approaches in clinical interventions for neurologic disorders in the United States: a scoping review and future directions for improving health equity research","volume":"101","author":"Boden-Albala","year":"2023","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2025.106579_bib0018","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/13524585241304976","article-title":"The onset presentation of multiple sclerosis differs in Hispanic\/Latinx Americans compared with non-hispanic white Americans","volume":"31","author":"Briggs","year":"2025","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2025.106579_bib0019","first-page":"732","article-title":"Characterizing patient assistance program use and patient responsiveness to specialty drug price for multiple sclerosis in a mid-size integrated health system","volume":"27","author":"Brouwer","year":"2021","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"4","key":"10.1016\/j.msard.2025.106579_bib0020","first-page":"451","article-title":"Comparisons of Latinos, African Americans, and Caucasians with multiple sclerosis","volume":"20","author":"Buchanan","year":"2010","journal-title":"Ethn. Dis."},{"key":"10.1016\/j.msard.2025.106579_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101930","article-title":"Socioeconomic deprivation increases the risk of disability in MS patients","volume":"40","author":"Calocer","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2025.106579_bib0022","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1352458519898590","article-title":"Barriers to access and utilization of multiple sclerosis care services in a large cohort of Latin American patients","volume":"27","author":"Carnero Contentti","year":"2021","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.msard.2025.106579_bib0023","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1177\/13524585211037578","article-title":"Comorbidities require special attention in minorities with multiple sclerosis","volume":"27","author":"Conway","year":"2021","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2025.106579_bib0024","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1352458516650512","article-title":"Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course","volume":"23","author":"Conway","year":"2017","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.msard.2025.106579_bib0025","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1212\/01.WNL.0000145762.60562.5D","article-title":"Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis","volume":"63","author":"Cree","year":"2004","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.msard.2025.106579_bib0026","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/jnnp-2024-333338","article-title":"Ethnicity and deprivation negatively impact the access to disease-modifying therapy for relapsing-remitting multiple sclerosis: a retrospective, single-centre study","volume":"95","author":"Das","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.msard.2025.106579_bib0027","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41582-022-00735-5","article-title":"SDOH in multiple sclerosis","volume":"18","author":"Dobson","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2025.106579_bib0028","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s11606-023-08051-4","article-title":"Modern day consequences of historic redlining: finding a path forward","volume":"38","author":"Egede","year":"2023","journal-title":"J. Gen. Intern. Med."},{"issue":"6","key":"10.1016\/j.msard.2025.106579_bib0029","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/jnnp-2021-328700","article-title":"Association of adverse childhood experiences with the development of multiple sclerosis","volume":"93","author":"Eid","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.msard.2025.106579_bib0030","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1186\/s12913-018-3584-x","article-title":"Racial disparities in Medicaid home and community-based service utilization and expenditures among persons with multiple sclerosis","volume":"18","author":"Fabius","year":"2018","journal-title":"BMC Health Serv. Res."},{"issue":"9","key":"10.1016\/j.msard.2025.106579_bib0031","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1177\/13524585231189678","article-title":"Enhancing involvement of people with multiple sclerosis in clinical trial design","volume":"29","author":"Gray","year":"2023","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2025.106579_bib0032","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7224\/1537-2073.2016-044","article-title":"Projecting the adequacy of the multiple sclerosis neurologist workforce","volume":"20","author":"Halpern","year":"2018","journal-title":"Int. J. MS Care"},{"issue":"4","key":"10.1016\/j.msard.2025.106579_bib0033","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41582-024-00941-3","article-title":"Building an ethnically and racially diverse neurology workforce","volume":"20","author":"Hamilton","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"13","key":"10.1016\/j.msard.2025.106579_bib0034","doi-asserted-by":"crossref","first-page":"e1497","DOI":"10.1212\/WNL.0000000000007190","article-title":"Socioeconomic status and disability progression in MS: a multinational study","volume":"92","author":"Harding","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106579_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102554","article-title":"The effect of out-of-pocket costs on initiation of disease-modifying therapies among medicare beneficiaries with multiple sclerosis","volume":"46","author":"Hartung","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.msard.2025.106579_bib0036","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7224\/1537-2073.2023-039","article-title":"Diversity, equity, and inclusion in the multiple sclerosis community: a call to action","volume":"25","author":"Hersh","year":"2023","journal-title":"Int. J. MS Care"},{"issue":"7","key":"10.1016\/j.msard.2025.106579_bib0037","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2023.1135","article-title":"Population-based estimates for the prevalence of multiple sclerosis in the United States by race, ethnicity, age, sex, and geographic region","volume":"80","author":"Hittle","year":"2023","journal-title":"JAMa Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106579_bib0038","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ncl.2016.06.016","article-title":"Epidemiology of multiple sclerosis","volume":"34","author":"Howard","year":"2016","journal-title":"Neurol. Clin."},{"issue":"8","key":"10.1016\/j.msard.2025.106579_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161701","article-title":"Associations of lifestyle, medication, and socio-demographic factors with disability in people with multiple sclerosis: an international cross-sectional study","volume":"11","author":"Jelinek","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.msard.2025.106579_bib0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.7224\/1537-2073.2021-103","article-title":"Telemedicine and multiple sclerosis: a survey of health care providers before and during the COVID-19 pandemic","volume":"24","author":"Keszler","year":"2022","journal-title":"Int. J. MS Care"},{"issue":"26","key":"10.1016\/j.msard.2025.106579_bib0041","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood-disadvantage metrics accessible - the neighborhood atlas","volume":"378","author":"Kind","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.msard.2025.106579_bib0042","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41582-021-00556-y","article-title":"Apparent changes in the epidemiology and severity of multiple sclerosis","volume":"17","author":"Koch-Henriksen","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2025.106579_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264328","article-title":"Do Hungarian multiple sclerosis care units fulfil international criteria?","volume":"17","author":"Kokas","year":"2022","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.msard.2025.106579_bib0044","doi-asserted-by":"crossref","first-page":"e1818","DOI":"10.1212\/WNL.0000000000200151","article-title":"Racial and ethnic disparities in multiple sclerosis prevalence","volume":"98","author":"Langer-Gould","year":"2022","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2025.106579_bib0045","doi-asserted-by":"crossref","first-page":"e4074","DOI":"10.1111\/hsc.13800","article-title":"Keeping it together: the role of social integration on health and psychological well-being among individuals with multiple sclerosis","volume":"30","author":"Latinsky-Ortiz","year":"2022","journal-title":"Health Soc. Care Community"},{"issue":"3","key":"10.1016\/j.msard.2025.106579_bib0046","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1212\/WNL.0000000000011276","article-title":"Geographic variation in neurologist density and neurologic care in the United States","volume":"96","author":"Lin","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106579_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105153","article-title":"Ethnic disparities in the epidemiological and clinical characteristics of multiple sclerosis","volume":"81","author":"Mallawaarachchi","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"9","key":"10.1016\/j.msard.2025.106579_bib0048","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1177\/13524585231189677","article-title":"Enhancing diversity of clinical trial populations in multiple sclerosis","volume":"29","author":"Marrie","year":"2023","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.msard.2025.106579_bib0049","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1212\/01.wnl.0000208505.81912.82","article-title":"Does multiple sclerosis-associated disability differ between races?","volume":"66","author":"Marrie","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106579_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2024.107544","article-title":"Virtual versus usual in-office care for multiple sclerosis: the VIRTUAL-MS multi-site randomized clinical trial study protocol","volume":"142","author":"McGinley","year":"2024","journal-title":"Contemp. Clin. Trials"},{"issue":"5_suppl","key":"10.1016\/j.msard.2025.106579_bib0051","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/13524585241292976","article-title":"Improving access to MS care through technology","volume":"30","author":"McGinley","year":"2024","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.msard.2025.106579_bib0052","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of MS: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMa"},{"issue":"2","key":"10.1016\/j.msard.2025.106579_bib0053","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207916","article-title":"Geographic disparities in access to neurologists and multiple sclerosis care in the United States","volume":"102","author":"McGinley","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106579_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.898043","article-title":"Toxic air pollutants and their effect on multiple sclerosis: a review study","volume":"10","author":"Mohammadi","year":"2022","journal-title":"Front. Public Health"},{"issue":"25","key":"10.1016\/j.msard.2025.106579_bib0055","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1901981","article-title":"Evobrutinib phase 2 study group. placebo-controlled trial of an oral BTK inhibitor in multiple sclerosis","volume":"380","author":"Montalban","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.msard.2025.106579_bib0056","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3390\/biomedicines11041227","article-title":"Health disparities in multiple sclerosis among hispanic and black populations in the United States","volume":"11","author":"Moore","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.msard.2025.106579_bib0057","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/ijerph21050529","article-title":"A rapid review of interventions to improve care for people who are medically underserved with multiple sclerosis, diabetic retinopathy, and lung cancer","volume":"21","author":"Mossburg","year":"2024","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.msard.2025.106579_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105842","article-title":"Multiple sclerosis in Somali Americans: nature or nurture?","volume":"90","author":"Nathoo","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106579_bib0059","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1215774","article-title":"Do magnetic resonance imaging features differ between persons with multiple sclerosis of various races and ethnicities?","volume":"14","author":"Nathoo","year":"2023","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2025.106579_bib0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7224\/1537-2073.2015-081","article-title":"Perceptions of multiple sclerosis in Hispanic Americans: need for targeted messaging","volume":"19","author":"Obiwuru","year":"2017","journal-title":"Int. J. MS Care"},{"issue":"1","key":"10.1016\/j.msard.2025.106579_bib0061","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/13524585231205969","article-title":"Re-thinking race and geography in multiple sclerosis","volume":"30","author":"Ontaneda","year":"2024","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.msard.2025.106579_bib0062","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1177\/13524585231185046","article-title":"SDOH and disparate disability accumulation in a cohort of Black, Hispanic, and White patients with multiple sclerosis","volume":"29","author":"Orlando","year":"2023","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.msard.2025.106579_bib0063","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5414\/CPP41277","article-title":"Clinical trials in Russia and Eastern Europe: recruitment and quality","volume":"41","author":"Platonov","year":"2003","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.msard.2025.106579_bib0064","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/13524585241254283","article-title":"Race and ethnicity in multiple sclerosis phase 3 clinical trials: a systematic review","volume":"30","author":"Ponzano","year":"2024","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.msard.2025.106579_bib0065","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1474-4422(21)00237-4","article-title":"Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial","volume":"20","author":"Reich","year":"2021","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.msard.2025.106579_bib0066","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/WCO.0000000000001264","article-title":"Current opinion: racial and ethnic health disparities in multiple sclerosis: considering the SDOH","volume":"37","author":"Robers","year":"2024","journal-title":"Curr. Opin. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2025.106579_bib0067","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1177\/13524585211019243","article-title":"Hypertension and hypertension severity in Hispanics\/Latinx with MS","volume":"27","author":"Robers","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106579_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104612","article-title":"Multiple sclerosis in Indigenous peoples of the Americas: a systematic review of incidence, prevalence, and outcomes","volume":"72","author":"Robers","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.msard.2025.106579_bib0069","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1177\/13524585211031791","article-title":"High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis","volume":"27","author":"Rotstein","year":"2021","journal-title":"Mult. Scler."},{"issue":"24","key":"10.1016\/j.msard.2025.106579_bib0070","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1212\/WNL.0000000000004025","article-title":"Racial disparities in neurologic health care access and utilization in the United States","volume":"88","author":"Saadi","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2025.106579_bib0071","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/hex.13554","article-title":"Improving diversity in study participation: patient perspectives on barriers, racial differences and the role of communities","volume":"25","author":"Shea","year":"2022","journal-title":"Health Expect."},{"key":"10.1016\/j.msard.2025.106579_bib0072","series-title":"Health Equity: A Solutions-Focused Approach","year":"2020"},{"issue":"5","key":"10.1016\/j.msard.2025.106579_bib0073","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/1352458518807082","article-title":"The multiple sclerosis care unit","volume":"25","author":"Soelberg Sorensen","year":"2019","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.msard.2025.106579_bib0074","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJMoa2201904","article-title":"Ublituximab versus teriflunomide in relapsing multiple sclerosis","volume":"387","author":"Steinman","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.msard.2025.106579_bib0075","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1212\/WNL.0000000000004508","article-title":"Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality","volume":"89","author":"Thormann","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106579_bib0076","unstructured":"U.S. Census Bureau (2023). New estimates highlight differences in growth between the U.S. Hispanic and non-hispanic populations. Retrieved from [https:\/\/www.census.gov\/newsroom\/press-releases\/2024\/population-estimates-characteristics.html]."},{"key":"10.1016\/j.msard.2025.106579_bib0077","series-title":"Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical trials: Guidance for Industry","first-page":"1","year":"2022"},{"issue":"12","key":"10.1016\/j.msard.2025.106579_bib0078","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1093\/brain\/awab342","article-title":"Socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosis","volume":"144","author":"Vasileiou","year":"2021","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.msard.2025.106579_bib0079","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1177\/1352458516679894","article-title":"Hispanic Americans and African Americans with multiple sclerosis have more severe disease course than Caucasian Americans","volume":"23","author":"Ventura","year":"2017","journal-title":"Mult. Scler."},{"issue":"2 Suppl","key":"10.1016\/j.msard.2025.106579_bib0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1352458516650742","article-title":"The patient's perspective: how to create awareness for improving access to care and treatment of MS patients?","volume":"22","author":"Vermersch","year":"2016","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2025.106579_bib0081","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/oxfordjournals.aje.a112493","article-title":"Latitude, migration, and the prevalence of multiple sclerosis","volume":"106","author":"Visscher","year":"1977","journal-title":"Am. J. Epidemiol."},{"issue":"10","key":"10.1016\/j.msard.2025.106579_bib0082","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209350","article-title":"Proportion of life spent in Canada and the incidence of multiple sclerosis in permanent immigrants","volume":"102","author":"Vyas","year":"2024","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.msard.2025.106579_bib0083","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106579_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104794","article-title":"Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial","volume":"76","author":"Williams","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2025.106579_bib0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ncl.2023.06.005","article-title":"Multiple sclerosis in black and Hispanic populations: serving the underserved","volume":"42","author":"Williams","year":"2024","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.msard.2025.106579_bib0086","unstructured":"World Health Organization. (2019). About SDOH. Retrieved from https:\/\/www.who.int\/health-topics\/social-determinants-of-health."},{"issue":"6","key":"10.1016\/j.msard.2025.106579_bib0087","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMsa1910366","article-title":"Patient and plan spending after state specialty-drug out-of-pocket spending caps","volume":"383","author":"Yeung","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2025.106579_bib0088","doi-asserted-by":"crossref","DOI":"10.1177\/13524585241311441","article-title":"Upper cervical spinal cord atrophy in MS: sex, menopause, and neurodegeneration","author":"Zeydan","year":"2025","journal-title":"Mult. Scler."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825003219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825003219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:41:10Z","timestamp":1755650470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825003219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":88,"alternative-id":["S2211034825003219"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106579","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating challenges and embracing opportunities toward achieving equitable multiple sclerosis care","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106579"}}